11/21
08:17 am
twst
DNA Synthesizer Market Projected to Reach USD 922.11 Million by 2032, Growing at a 14.62% CAGR – SNS Insider [Yahoo! Finance]
Low
Report
DNA Synthesizer Market Projected to Reach USD 922.11 Million by 2032, Growing at a 14.62% CAGR – SNS Insider [Yahoo! Finance]
11/20
05:26 am
twst
Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
Low
Report
Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
11/19
11:09 am
twst
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $55.00 to $52.00. They now have an "overweight" rating on the stock.
Low
Report
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $55.00 to $52.00. They now have an "overweight" rating on the stock.
11/19
10:36 am
twst
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Scotiabank from $50.00 to $54.00. They now have a "sector outperform" rating on the stock.
Low
Report
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Scotiabank from $50.00 to $54.00. They now have a "sector outperform" rating on the stock.
11/19
08:18 am
twst
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Robert W. Baird from $46.00 to $48.00. They now have an "outperform" rating on the stock.
Low
Report
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Robert W. Baird from $46.00 to $48.00. They now have an "outperform" rating on the stock.
11/19
02:08 am
twst
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
11/18
12:23 pm
twst
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps [Yahoo! Finance]
Low
Report
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps [Yahoo! Finance]
11/18
07:17 am
twst
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results [Yahoo! Finance]
Medium
Report
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results [Yahoo! Finance]
11/18
07:15 am
twst
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
Medium
Report
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
11/15
11:02 pm
twst
Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
High
Report
Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
11/14
08:12 am
twst
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
High
Report
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
11/14
08:00 am
twst
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
High
Report
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
11/7
04:05 pm
twst
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
10/30
08:00 am
twst
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
Low
Report
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
10/24
08:00 am
twst
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
Medium
Report
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
10/22
09:23 am
twst
Twist Bioscience enters into purchase agreement with XOMA Royalty [Seeking Alpha]
Low
Report
Twist Bioscience enters into purchase agreement with XOMA Royalty [Seeking Alpha]
10/22
08:00 am
twst
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
Medium
Report
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
10/17
11:36 am
twst
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Leerink Partners from $45.00 to $48.00. They now have a "market perform" rating on the stock.
Low
Report
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Leerink Partners from $45.00 to $48.00. They now have a "market perform" rating on the stock.
10/15
08:00 am
twst
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
Low
Report
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
10/1
01:17 pm
twst
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Evercore ISI from $52.00 to $56.00. They now have an "outperform" rating on the stock.
Low
Report
Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Evercore ISI from $52.00 to $56.00. They now have an "outperform" rating on the stock.
9/13
07:24 am
twst
Investors ignore increasing losses at Twist Bioscience (NASDAQ:TWST) as stock jumps 11% this past week [Yahoo! Finance]
Medium
Report
Investors ignore increasing losses at Twist Bioscience (NASDAQ:TWST) as stock jumps 11% this past week [Yahoo! Finance]
9/12
08:00 am
twst
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
Low
Report
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
9/9
08:00 am
twst
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
Low
Report
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
8/28
04:21 am
twst
Genome Sequencing Market Analysis, Competitive Benchmarking and Company Profiles Report 2024-2033: Emergence of Portable Genome Sequencing Enabling Bedside Testing Presents Market Opportunities [Yahoo! Finance]
Low
Report
Genome Sequencing Market Analysis, Competitive Benchmarking and Company Profiles Report 2024-2033: Emergence of Portable Genome Sequencing Enabling Bedside Testing Presents Market Opportunities [Yahoo! Finance]
8/27
08:00 am
twst
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
Low
Report
Twist Bioscience to Present at Baird Global Healthcare Conference 2024